How A UK Tech Start-Up Is Disrupting Men’s Health
Executive Summary
HBW Insight talks to Numan's chief medical strategy officer Professor Sam Shah about how the UK tech start-up is bringing innovation to the country's men's health category.
You may also be interested in...
Numan Adds Automation To Its Digital Consumer Health Offer With Vi-Health Acquisition
UK men's health platform Numan continues its mission of disrupting the consumer health industry with its acquisition of Sweden’s Vi-Health technology – a Class I medical device that includes an artificial intelligence-powered symptom checker, as well as advanced e-consultation and workflow automation tools.
Futura’s Revolutionary ED Treatment One Step Closer To US And EU OTC Approval
US and EU OTC approval for Futura's drug-free erectile dysfunction treatment MED3000 edges closer, following the company's submission of its EU dossier and a second pre-submission meeting with the FDA.
EMA Approves EU-Wide Rx-to-OTC Switch Of Fortacin
Premature ejaculation treatment Fortacin is set to become only the fifth drug to achieve an Rx-to-OTC switch through EMA's centralized procedure, expanding the burgeoning OTC men's sexual health category.